Strategy vaccination against Hepatitis B in China

References

• World Health Organization. Hepatitis B. Fact sheet N°204 Updated July 2014. http://www.who.int/mediacentre/factsheets/fs204/en/
   Google Scholar
• World Health Organization. Prevention & control of viral hepatitis infection: framework for global action. 2012
   Google Scholar
• World Health Organization. Department of communicable disease surveillance and response. Hepatitis B 2002; 2:1–76; http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/
   Google Scholar
• World Health Organization: Expanded Programme on Immunization. Global advisory group. Weekly Epidemiol Rec 1992; 67:11–6.
   PubMedGoogle Scholar
• Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ; Advisory Committee on Immunization Practices (ACIP). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: Immunization of infants, children, and adolescents. MMWR Recomm Rep 2005 Dec 23; 54(RR-16):1–31; PMID:16371945
   PubMedGoogle Scholar
• Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM Jr, Janssen RS, Ward JW; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006 Dec 8; 55(RR-16):1–33; PMID:17159833
   PubMedGoogle Scholar
• Chien YC, Jan CF, Kuo HS, Chen CJ. Nationwide hepatitis B vaccination program in Taiwan: Effectiveness in the 20 years after it was launched. Epidemiol Rev 2006; 28:126–35; PMID:16782778; http://dx.doi.org/10.1093/epirev/mxj010
   PubMed Web of Science ®Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Epidemiological serosurvey of hepatitis B in China—declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27:6550–7; PMID:19729084; http://dx.doi.org/10.1016/j.vaccine.2009.08.048
   PubMed Web of Science ®Google Scholar
• Zhuang H. Hepatitis B vaccination in China. Basic Med Sci Clin 2004; 24:136–40
   Google Scholar
• Wang XJ. Chinese GAVI program. Chinese J Public Health Manage 2004; 20:410–12
   Google Scholar
• Wang Y, Jia J. Control of hepatitis B in China: prevention and treatment. Expert Rev Anti Infect Ther 2011; 9:21–5; PMID:21171874; http://dx.doi.org/10.1586/eri.10.143
   PubMed Web of Science ®Google Scholar
• Cui FQ, Gong XH, Chen YS, Wang FZ, Zheng H, Hu YS, Wu ZH, Wang HQ, Liang XF. Chinese hepatitis B immunization strategies and feasibility of expanding the vaccination to children and high risk population among adult. Chinese J Vaccines Immunization 2008; 14:553–8
   Google Scholar
• Dang RB, Zhang SX, Zhang WD, Liang XF, Cui FQ, Zhao F. Assessment for immune effectiveness of hepatitis B vaccination among infant population in China. Chinese J Public Health 2009; 4:6–8
   Google Scholar
• Chinese Society of Hepatology, Chinese Medical Association and Chinese Society of Infectious Diseases, Chinese Medical Association. Guideline on prevention and treatment of chronic hepatitis B in China (2010). J Clini Hepatol 2011; 27:I–XVI
   Google Scholar
• Cui FQ. Chinese Prevention Medicine Association, National Immunization Program, Chinese Center for Disease Control and Prevention. Technical guide for adult hepatitis B immunization in China. Chinese J Epidemiol 2011; 32:1199–03; PMID:22336599
   PubMedGoogle Scholar
• Zanetti AR, Mariano A, Romano L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: An Italian multicentre study. Lancet 2005; 366:1379–84; PMID:16226616; http://dx.doi.org/10.1016/S0140-6736(05)67568-X
   PubMed Web of Science ®Google Scholar
• John TJ, Cooksley G. Hepatitis B vaccine boosters: Is there a clinical need in high endemicity populations. J Gastroenterol Hepatol 2005; 20:5–10; PMID:15610440
   PubMedGoogle Scholar
• Zhang YF. The effects of HBV immunization of health care workers over ten years. Occup Health 2001; 17:37
   Google Scholar
• Ryckman KK, Fielding K, Hill AV, Mendy M, Rayco-Solon P, Sirugo G, van der Sande MA, Waight P, Whittle HC, Hall AJ, et al. Host genetic factors and vaccine-induced immunity to HBV infection: Haplotype analysis. PLoS One 2010, 5:e12273; PMID:20806065; http://dx.doi.org/10.1371/journal.pone.0012273
   PubMed Web of Science ®Google Scholar
• Shaw FE Jr, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, Roehm RR Jr, Talley WS, Hadler SC. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989, 7:425–30; PMID:2530717; http://dx.doi.org/10.1016/0264-410X(89)90157-6
   PubMed Web of Science ®Google Scholar
• Andre FE. Summary of safety and efficacy data on a yeast-derived hepatitis B vaccine. Am J Med 1989; 87:S14–20; PMID:2528292; http://dx.doi.org/10.1016/0002-9343(89)90525-1
   PubMed Web of Science ®Google Scholar
• Marinho RT, Moura MC, Pedro M, Ramalho FJ, Velosa JF. Hepatitis B vaccination in hospital personnel and medical students. J Clin Gas-Netroenterol 1999; 28:317–22; PMID:10372928; http://dx.doi.org/10.1097/00004836-199906000-00007
   PubMedGoogle Scholar
• Rogan PD, Duguid JKM. Immunisation of staff of a regional blood transfusion centre with a recombinant hepatitis B vaccine. J Infect 1991; 22:5–9; PMID:1825836; http://dx.doi.org/10.1016/0163-4453(91)90786-R
   PubMed Web of Science ®Google Scholar
• Hadler SC, de Monzon MA, Lugo DR, Perez M. Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians. Vaccine 1989; 7:106–10; PMID:2526419; http://dx.doi.org/10.1016/0264-410X(89)90046-7
   PubMed Web of Science ®Google Scholar
• Greenberg DP, Vadheim CM, Wong VK, Marcy SM, Partridge S, Greene T, Chiu CY, Margolis HS, Ward JI. Comparative safety and immunogenicity of two recombinant hepatitis B vaccines given to infants at two, four and six months of age. Pediatr Infect Dis J 1996; 15:590–6; PMID:8823852; http://dx.doi.org/10.1097/00006454-199607000-00006
   PubMedGoogle Scholar
• Leroux-Roels G, Abraham B, Fourneau M, De Clercq N, Safary A. A comparison of two commercial recombinant vaccines for hepatitis B in adolescents. Vaccine 2001; 19:937–42; PMID:11115719; http://dx.doi.org/10.1016/S0264-410X(00)00217-6
   PubMedGoogle Scholar
• Haubitz M, Ehlerding G, Beigel A, Heuer U, Hemmerling AE, Thoma HA. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency. Clin Nephrol 1996; 45:180–2; PMID:8706359
   PubMed Web of Science ®Google Scholar
• Treadwell TL, Keeffe EB, Lake J, Read A, Friedman LS, Goldman IS, Howell CD, DeMedina M, Schiff ER, Jensen DM, et al. Immunogenicity of two recombinant hepatitis B vaccines in older individuals. Am J Med 1993; 95:584–8; PMID:8259774; http://dx.doi.org/10.1016/0002-9343(93)90353-Q
   PubMed Web of Science ®Google Scholar
• Banatvala J, Van Damme P, Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine 2000; 19:877–85; PMID:11115711; http://dx.doi.org/10.1016/S0264-410X(00)00224-3
   PubMed Web of Science ®Google Scholar
• Rendi-Wagner P, Kundi M, Stemberger H, Wiedermann G, Holzmann H, Hofer M, Wiesinger K, Kollaritsch H. Antibody response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience. Vaccine 2001; 19:2055–60; PMID:11228377; http://dx.doi.org/10.1016/S0264-410X(00)00410-2
   PubMed Web of Science ®Google Scholar
• Su FH, Bai CH, Chu FY, Lin YS, Su CT, Yeh CC. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan. Vaccine 2012; 30:4034–9; PMID:22531558; http://dx.doi.org/10.1016/j.vaccine.2012.04.031
   PubMedGoogle Scholar
• Liao XY, Zhou ZZ, Wei FB, Qin HN, Ling Y, Li RC, Li YP, Nong Y, Sun KX, Li J, et al. Seroprevalence of hepatitis B and immune response to hepatitis B vaccination in Chinese college students mainly from the rural areas of western China and born before HBV vaccination integrated into expanded program of immunization. Hum Vaccin Immunother 2014; 10:224–31; PMID:24018404; http://dx.doi.org/10.4161/hv.26311
   PubMed Web of Science ®Google Scholar
• Viviani S, Jack A, Hall AJ, Maine N, Mendy M, Montesano R, Whittle HC. Hepatitis B vaccination in infancy in the Gambia: Protection against carriage at 9 years of age. Vaccine 1999; 17:2946–50; PMID:10462228; http://dx.doi.org/10.1016/S0264-410X(99)00178-4
   PubMed Web of Science ®Google Scholar
• Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, Bell BP. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: A 15-year follow-up study. Pediatric Infect Dis J 2008; 27:881–5; PMID:18756185; http://dx.doi.org/10.1097/INF.0b013e31817702ba
   PubMed Web of Science ®Google Scholar
• Floreani A, Baldo V, Cristofoletti M, Renzulli G, Valeri A, Zanetti C, Trivello R. Long-term persistence of anti-HBs after vaccination against HBV: An 18 year experience in health care workers. Vaccine 2004; 22:607–10; PMID:14741151; http://dx.doi.org/10.1016/j.vaccine.2003.09.001
   PubMed Web of Science ®Google Scholar
• Goldstein ST, Alter MJ, Williams IT, Moyer LA, Judson FN, Mottram K, Fleenor M, Ryder PL, Margolis HS. Incidence and risk factors for acute hepatitis B in the United States, 1982–1998: Implications for vaccination programs. J Infect Dis 2002; 185:713–9; PMID:11920288; http://dx.doi.org/10.1086/339192
   PubMed Web of Science ®Google Scholar
• World Health Organization. Hepatitis B vaccine. Weekly Epidemiological Record 2009; 84:405–19. http://www.who.int/wer
   PubMedGoogle Scholar
• Department of Disease Control, Ministry of Health. National survey on immunization and hepatitis B coverage and its influencing factors in 1999. Chinese J Vaccines Immunization 2000; 6:193–7
   Google Scholar
• Ministry of Health. Report of national expanded programme on immunization review in 2004 [Chinese]. Beijing, China: People's Health Express 2005; 7–8.
   Google Scholar
• Zhang SY, Si Q, Zhao P, Zhao YY, Yan XE. Study of immunization rates and factors influencing vaccination with hepatitis B vaccine among children in the City of Erdos. J Dis Monitor Control 2012; 6:385–7
   Google Scholar
• Liang S, Zhang SHX, Ma QSH, Xiao WH, Xie X, Mei SJ, Hu DS, Zhou BP, Li B, Cui FQ, et al. Study on the direct economic burden of hepatitis B and its economic impact on families in the City of Shenzhen. Chinese Health Economics 2011; 30:56–8
   Google Scholar
• Bock HL, Kruppenbacher J, Sänger R, Höbel W, Clemens R, Jilg W. Immunogenicity of a recombinant hepatitis B vaccine in adults. Arch Intern Med 1996; 156:2226–31; PMID:8885822; http://dx.doi.org/10.1001/archinte.1996.00440180088011
   PubMed Web of Science ®Google Scholar
• Zajac BA, West DJ, McAleer WJ, Scolnick EM. Overview of clinical studies with hepatitis B vaccine made by recombinant DNA. J Infect 1986; 13:39–45; PMID:2943814; http://dx.doi.org/10.1016/S0163-4453(86)92668-X
   PubMed Web of Science ®Google Scholar
• Averhoff F, Mahoney F, Coleman P, Schatz G, Hurwitz E, Margolis H. Immunogenicity of hepatitis B vaccines: Implications for persons at occupational risk for hepatitis B virus infection. Am J Prev Med 1998; 15:1–8 ; 1ide; PMID:9651632; http://dx.doi.org/10.1016/S0749-3797(98)00003-8
   PubMed Web of Science ®Google Scholar
• Weber DJ, Rutala WA, Samsa GP, Santimaw JE, Lemon SM. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 1985; 254:3187–9; PMID:2933532; http://dx.doi.org/10.1001/jama.1985.03360220053027
   PubMed Web of Science ®Google Scholar
• Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 1993; 270:2935–9; PMID:8254853; http://dx.doi.org/10.1001/jama.1993.03510240047030
   PubMed Web of Science ®Google Scholar
• Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SJ, Dienstag JL, Awdeh Z, Yunis EJ. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989; 321:708–12; PMID:2528067; http://dx.doi.org/10.1056/NEJM198909143211103
   PubMed Web of Science ®Google Scholar